<div id="readability-page-1"><p>Blue Trust Inc. lowered its position in  HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 11.1% in the third quarter, according to the company in its most recent Form 13F filing with the Securities &amp; Exchange Commission. The firm owned 26,384 shares of the company's stock after selling 3,294 shares during the period. Blue Trust Inc.'s holdings in HCA Healthcare were worth $11,245,000 as of its most recent filing with the Securities &amp; Exchange Commission.</p><div><p><span></span><span>Get <strong>HCA Healthcare</strong> alerts:</span></p></div><ul><li>MarketBeat Week in Review – 07/28 - 08/01</li></ul><p>Several other large investors also recently bought and sold shares of HCA. Norges Bank purchased a new position in shares of  HCA Healthcare during the 2nd quarter worth approximately $1,152,408,000.  Viking Global Investors LP raised its position in  HCA Healthcare by 58.5% in the second quarter. Viking Global Investors LP now owns 1,872,133 shares of the company's stock valued at $717,214,000 after purchasing an additional 690,773 shares during the period.  Nordea Investment Management AB increased its stake in  HCA Healthcare by 6.8% during the 2nd quarter. Nordea Investment Management AB now owns 927,781 shares of the company's stock worth $350,404,000 after buying an additional 59,163 shares during the period.  Pacer Advisors Inc. raised its position in shares of  HCA Healthcare by 6,115.3% in the 3rd quarter. Pacer Advisors Inc. now owns 911,096 shares of the company's stock valued at $388,309,000 after purchasing an additional 896,437 shares in the last quarter.  Finally, LSV Asset Management grew its stake in  HCA Healthcare by 0.4% in the second quarter. LSV Asset Management now owns 868,849 shares of the company's stock worth $332,856,000 after purchasing an additional 3,396 shares in the last quarter. Institutional investors and hedge funds own  62.73% of the company's stock. </p><h2>Analyst Ratings Changes</h2><p>A number of analysts have recently weighed in on HCA shares. Raymond James Financial  set a $525.00 price target on HCA Healthcare in a research report on Monday, October 27th. Oppenheimer boosted their price target on HCA Healthcare from $400.00 to $500.00 and gave the stock an &#34;outperform&#34; rating in a research report on Monday, October 27th. Wells Fargo &amp; Company raised their target price on HCA Healthcare from $412.00 to $431.00 and gave the company an &#34;equal weight&#34; rating in a research note on Thursday, November 13th. Bank of America lifted their price target on HCA Healthcare from $430.00 to $470.00 and gave the stock a &#34;neutral&#34; rating in a research note on Monday, October 27th. Finally, Zacks Research lowered shares of HCA Healthcare from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a research report on Thursday, November 27th. Fourteen equities research analysts have rated the stock with a Buy rating, nine have given a Hold rating and one  has assigned  a Sell rating to the company. According to MarketBeat.com, HCA Healthcare currently has a consensus rating of &#34;Moderate Buy&#34; and a consensus price target of $479.00.</p><ul><li>Can HCA Healthcare Revive the Market’s Weakest Sector?</li></ul><p><b>Read Our Latest Stock Report on HCA</b></p><h2>Insider Buying and Selling at HCA Healthcare</h2><p>In other news, EVP Michael R. Mcalevey sold 3,892 shares of the firm's stock in a transaction on Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total value of $1,843,990.68. Following the transaction, the executive vice president directly owned 3,487 shares in the company, valued at $1,652,105.73. This trade represents a 52.74% decrease in their position. The transaction was disclosed in a document filed with the Securities &amp; Exchange Commission, which is available at this link. 1.30% of the stock is currently owned by company insiders. </p><h2>HCA Healthcare Trading Up 0.0%</h2><ul><li>Can Integrated Healthcare Stocks Succeed in Public Markets?</li></ul><p>Shares of NYSE:HCA opened at $474.06 on Friday. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $520.00. The business's 50 day moving average is $474.62 and its 200-day moving average is $419.32. The firm has a market capitalization of $108.18 billion, a PE ratio of 18.32, a PEG ratio of 1.40 and a beta of 1.36. </p><p>HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings results on Friday, October 24th. The company reported $6.96 earnings per share for the quarter, beating analysts' consensus estimates of $5.64 by $1.32. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The firm had revenue of $19.16 billion for the quarter, compared to analysts' expectations of $18.55 billion. During the same period in the prior year, the business posted $4.90 earnings per share. The business's revenue was up 9.6% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS.  On average, sell-side analysts predict that  HCA Healthcare, Inc. will post 24.98 EPS for the current year. </p><h2>HCA Healthcare Announces Dividend</h2><p>The company also recently disclosed a quarterly dividend, which will be paid on Monday, December 29th. Investors of record on Monday, December 15th will be given a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date is Monday, December 15th. HCA Healthcare's dividend payout ratio (DPR) is presently 11.13%. </p><h2>HCA Healthcare Profile</h2> (Free Report)<p>HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.  </p><p>The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.</p><h2>Recommended Stories</h2><ul><li>Five stocks we like better than HCA Healthcare</li><li>Put $1,000 into this stock by Jan 1 [Not NVDA]</li><li>Turn your &#34;dead money&#34; into $306+ monthly (starting this month)</li><li>Washington prepares for war</li><li>Strange Crystal Metal Outperforms Silicon Up to 100X</li><li>33,000% boom from weird new “AI Fuel?”</li></ul><p><strong>Want to see what other hedge funds are holding HCA?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).</p><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhDQQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhDQQ"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in HCA Healthcare Right Now?</h2><p>Before you consider HCA Healthcare, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.</p><p>While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Blue Trust Inc. reduced its stake in HCA Healthcare by 11.1% in Q3, owning 26,384 shares worth $11.2M. Analysts have varied ratings, with a consensus of "Moderate Buy" and a price target of $479.00. HCA's stock opened at $474.06, with a 1-year range of $289.98-$520.00. The company reported Q3 earnings of $6.96 per share, surpassing estimates, with revenue up 9.6% to $19.16B.</p>

Blue Trust Inc. Trims Stock Position in HCA Healthcare, Inc. $HCA